A survey on cerebral infarction/transient ischemic attack inpatients compliance with secondary stroke prevention and follow-up 90 days

National Medical Journal of China

Volumn 88, Issue 37, 2008, Pages 2618-2622

  Ma, Rui Hua ^a   Wang, Yong Jun ^b   Wang, Chun Xue ^b   Zhao, Xing Quan ^b   Wang, Yin Long ^b   Xu, Ming Jie ^b   Wei, Ming ^b   Li, Yao ^b   Zhang, Zhuo ^b   Zhang, Wei Wei ^b   Wang, Li ^b   Lin, Lang ^b   Li, Hong Tao ^b   Zheng, Ting ^b   Wang, Xian Wei ^b   Li, Jing Jing ^b   Lü, Ying ^b   Qi, Dong ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

Brain infarction; Ischemic attack, transient; Patient compliance; Secondary prevention

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; BRAIN INFARCTION; CAROTID ENDARTERECTOMY; CEREBROVASCULAR ACCIDENT; CHINA; CLINICAL PRACTICE; CONTROLLED STUDY; DEMOGRAPHY; EVIDENCE BASED MEDICINE; FEMALE; FOLLOW UP; HEALTH SURVEY; HOSPITAL PATIENT; HUMAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRACTICE GUIDELINE; RECURRENCE RISK; RISK ASSESSMENT; RISK FACTOR; SECONDARY PREVENTION; SMOKING CESSATION; STENT; TRANSIENT ISCHEMIC ATTACK; WEIGHT CONTROL;

AGED; CEREBRAL INFARCTION; DRUG UTILIZATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INPATIENTS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES; SECONDARY PREVENTION;

EID: 56349123406     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Bronner LL, Kanter DS, Manson JE. Primary prevention of stroke. N Engl J Med, 1995,333:1392-1400.
2. Meissner I, Whisnant JP, Garraway WM. Hypertension management and stroke recurrence in a community (Rochester, Minnesota, 1950-79). Stroke, 1988,19:459-463.
3. Geut M, Blakely JA, Hachinski V, et al. A secondary prevention, randomized trial of suloctidil in patients with a recent history of thromboembolic stroke. Stroke, 1985,16:416-424.
4. Chinese source.
5. Hardie K, Hankey GJ, Jamrozik K, et al. Ten-year risk of first recurrent stroke and disability after first-ever stroke in the Perth Community Stroke Study. Stroke,2004,35:731-735.
6. Moroney J, Bagiella E, Paik MC, et al. Risk factors for early recurrence after ischemic stroke: the role of stroke syndrome and subtype. Stroke,1998,29:2118-2124.
7. Sandercock P. Should I start all my ischaemic stroke and TIA patients on a statin, an ACE inhibitor, a diuretic, and aspirin today? J Neurol Neurosurg Psychiatry,2003,74:1461-1464.
8. Hamann G, Weimar C, Glahn J, et al. Adherence to secondary stroke prevention strategies-results from the German Stroke Data Bank. Cerebrovasc Dis,2003,15:282-288.
9. Mouradian M, Majumdar SR, Senthilselvan A, et al. How well are hypertension, hyperlipidemia, diabetes, and smoking managed after a stroke or transient ischemic attack? Stroke, 2002, 33: 1656-1659.
10. Hillen T, Dundas R, Lawrence E, et al. Antithrombotic and antihypertensive management 3 months after ischemic stroke: a prospective study in an inner city population. Stroke, 2000, 31: 469-475.
11. Dergalust S, Rofail MT, Bateshansky DS, et al. The incidence of discontinuation of extended release dipyridamole/aspirin, clopidogrel and warfarin for the secondary prevention of stroke. Presented at the 55th Am Academy of Neurology Annual Meeting in Honolulu, Hawaii, April 3, 2003.
12. Wang Y, Wu D, Wang Y, et al. A survey on adherence to secondary ischemic stroke prevention. Neurol Res, 2006,28:16-20.
13. Ovbiagele B, Saver JL, Fredieu A, et al. In-hospital initiation of secondary stroke prevention therapies yields high rates of adherence at follow-up. Stroke,2004,35: 2879-2883.
14. Sacco RL, Adams R, Albers G, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack. Stroke,2006,37:577-617.